Compound Detail
CHEMBL5194948
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1cccc(-c2cc(C#N)cc(Oc3c(C(F)(F)F)ccn(Cc4n[nH]c(=O)n4C)c3=O)c2)c1
Basic Information
| ChEMBL ID | CHEMBL5194948 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MCXDFOKNYPFMIS-UHFFFAOYSA-N |
5
Targets
12
Activities
2
Assay Types
15
PK Parameters
10
Publications
0
Known Names
Molecular Properties
481.4
MW (Da)
3.98
ALogP
7
HBA
1
HBD
105.7
PSA (Ų)
0.46
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 8 meas. best 7.89
IC50 4 meas. best 7.39
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 7.89 | 6.9375 | 13.0 | 8 |
| Human immunodeficiency virus type 1 reverse transcriptase CHEMBL247 | IC50 | 7.39 | 7.39 | 41.0 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 4.6 | 4.6 | 25300.0 | 1 |
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 4.54 | 4.54 | 28600.0 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 4.42 | 4.42 | 38300.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 891.94 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 4983.22 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 940.41 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 6594.05 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 17.87 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 13.19 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 973.56 | nM | Rattus norvegicus |
| Cmax | 1211.6 | nM | Rattus norvegicus |
| F | 140.24 | % | Rattus norvegicus |
| MRT | 2.48 | hr | Rattus norvegicus |
| MRT | 13.92 | hr | Rattus norvegicus |
| T1/2 | 1.9 | hr | Rattus norvegicus |
| T1/2 | 8.45 | hr | Rattus norvegicus |
| Tmax | 0.08 | hr | Rattus norvegicus |
| Tmax | 6.67 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35797898 | 10.1016/j.ejmech.2022.114581 | ADMET | 27 |
| 35797898 | 10.1016/j.ejmech.2022.114581 | Human immunodeficiency virus 1 | 9 |
| 35797898 | 10.1016/j.ejmech.2022.114581 | Cytochrome P450 3A4 | 2 |
| 35797898 | 10.1016/j.ejmech.2022.114581 | MT4 | 1 |
| 35797898 | 10.1016/j.ejmech.2022.114581 | Human immunodeficiency virus type 1 reverse transcriptase | 1 |
| 35797898 | 10.1016/j.ejmech.2022.114581 | Cytochrome P450 1A2 | 1 |
| 35797898 | 10.1016/j.ejmech.2022.114581 | Cytochrome P450 2C9 | 1 |
| 35797898 | 10.1016/j.ejmech.2022.114581 | Cytochrome P450 2C19 | 1 |
| 35797898 | 10.1016/j.ejmech.2022.114581 | Cytochrome P450 2D6 | 1 |
| 35797898 | 10.1016/j.ejmech.2022.114581 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
Data from ChEMBL 36 via Core Engine